Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Prerequisites for establishing a public human UCB SCB; assessment of public acceptance and resistance of UCB to HIV

Thesis (PhD)--University of Pretoria, 2012.

Saved in:
Bibliographic Details
Other Authors: Pepper, Michael Sean
Format: Thesis
Published: University of Pretoria 2013
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613577472376832
access_status_str Open Access
author2 Pepper, Michael Sean
author_browse Pepper, Michael Sean
author_facet Pepper, Michael Sean
collection Thesis
dc_rights_str_mv © 2012 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria.
description Thesis (PhD)--University of Pretoria, 2012.
format Thesis
id oai:repository.up.ac.za:2263/24166
institution University of Pretoria (South Africa)
last_indexed 2026-06-10T12:38:21.763Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2013
publishDateRange 2013
publishDateSort 2013
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/24166 Prerequisites for establishing a public human UCB SCB; assessment of public acceptance and resistance of UCB to HIV Pepper, Michael Sean mmroloff@gmail.com Meissner-Roloff, Madelein Public umbilical cord blood stem cell bank Gene therapy Infectious diseases Antiretroviral therapy (ART) Haematopoietic progenitor cells UCTD Thesis (PhD)--University of Pretoria, 2012. South Africa is in dire need of a public umbilical cord blood stem cell bank (UCB SCB). A severe shortage of genetically compatible samples for BM transplantation precludes the majority of South Africans from receiving the relevant medical care. UCB is a viable alternative to BM but is currently disposed of post-delivery. UCB could furthermore serve as a resource of genetically compatible haematopoietic progenitor cells (HPCs) that could be used in gene therapy approaches directed towards a cure for HIV-1. Knowing whether HIV-1 affects or infects primitive HPCs is vital to determine the course of action for transplantation of UCB-derived genetically resistant HPCs. Collecting and storing UCB in a public UCB bank could thus serve as a vital resource of genetically compatible samples for BM transplantation. It was thought that the high incidence of HIV-1 in South African patients and the persistent stigma surrounding HIV-1 would be problematic for collecting sustainable numbers of UCB units and subjecting units to compulsory screening for infectious diseases. This was however, not the case. In the South African context, we are faced with unique and rich challenges relating to cultural and religious differences that are further augmented by linguistic constraints and educational insufficiencies. Nevertheless, the majority of patients within the interviewed patient cohort were supportive of the idea of establishing a public UCB SCB in SA and were willing to undergo additional HIV-1 screening. The Ultrio-Plus® assay was verified in this study for screening UCB units for HIV-1 and could be used in routine analyses of UCB units prior to banking. Conflicting results in the literature exist with regard to HIV-1’s ability to infect or affect haematopoietic progenitor cells. Results from this study revealed that HIV-1 was not only able to affect HPCs’ ability to form colonies in vitro, but was also capable of infecting CD34+ HPCs in some individuals. These results substantiate the theory that some CD34+ HPCs serve as viral reservoirs which could account for residual viraemia in patients on antiretroviral therapy. Results suggest that allogeneic transplantation of HIV-1 infected individuals with UCB-derived, genetically modified HPCs, should be pursued. Immunology unrestricted 2013-09-06T16:49:01Z 2013-05-17 2013-09-06T16:49:01Z 2013-04-05 2012 2013-04-26 Thesis Meissner-Roloff, M 2012, Prerequisites for establishing a public human UCB SCB; assessment of public acceptance and resistance of UCB to HIV, PhD thesis, University of Pretoria, Pretoria, viewed yymmdd < http://hdl.handle.net/2263/24166 > D13/4/412/ag http://hdl.handle.net/2263/24166 http://upetd.up.ac.za/thesis/available/etd-04262013-152143/ © 2012 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf application/pdf application/pdf application/pdf application/pdf application/pdf application/pdf University of Pretoria
spellingShingle Public umbilical cord blood stem cell bank
Gene therapy
Infectious diseases
Antiretroviral therapy (ART)
Haematopoietic progenitor cells
UCTD
Prerequisites for establishing a public human UCB SCB; assessment of public acceptance and resistance of UCB to HIV
title Prerequisites for establishing a public human UCB SCB; assessment of public acceptance and resistance of UCB to HIV
title_full Prerequisites for establishing a public human UCB SCB; assessment of public acceptance and resistance of UCB to HIV
title_fullStr Prerequisites for establishing a public human UCB SCB; assessment of public acceptance and resistance of UCB to HIV
title_full_unstemmed Prerequisites for establishing a public human UCB SCB; assessment of public acceptance and resistance of UCB to HIV
title_short Prerequisites for establishing a public human UCB SCB; assessment of public acceptance and resistance of UCB to HIV
title_sort prerequisites for establishing a public human ucb scb assessment of public acceptance and resistance of ucb to hiv
topic Public umbilical cord blood stem cell bank
Gene therapy
Infectious diseases
Antiretroviral therapy (ART)
Haematopoietic progenitor cells
UCTD
url http://hdl.handle.net/2263/24166
http://upetd.up.ac.za/thesis/available/etd-04262013-152143/